Neurology
Stroke, TIA, emergency neurology, and brain health.
Clear, practical health guides
Evidence-based content on metabolic health, chronic disease, and everyday health decisions — no fluff, no sensationalism.
Browse All GuidesFeatured Guide Hubs
Curated topic hubs — rotates weekly
Mental Health
Anxiety, depression, ADHD, sleep, and evidence-based care.
Metabolic Health
Weight, insulin resistance, GLP-1s, and cardiometabolic risk.
Aging & Longevity
Aging biology, lifespan heritability, and longevity debates.
Latest Posts
Peptide Therapy in the U.S.: The Market Moved First — Now the Rules Are Catching Up
Demand for peptide therapy is exploding in the U.S., but regulation is still trying to define what’s legal, safe, and real medicine.
Utah’s AI Prescription Renewal Experiment: The Pros, the Cons, and the Bigger Question
Utah is piloting AI-driven prescription renewals for chronic medications. The idea could improve access and reduce friction, but it also raises important questions about safety, accountability, transparency, and the loss of clinical touchpoints.
The GLP-1 Adherence Crisis
Most GLP-1 patients stop within a year. Here's why adherence — not efficacy — is the defining challenge in metabolic therapy.
The Real GLP-1 Problem Isn’t Starting — It’s Staying On
A new BMJ Medicine study suggests stopping GLP-1 drugs may quickly erase their cardiovascular benefits.
Who Needs Blood Pressure Medication in 2026? What Changed in the New Guidelines
New hypertension guidelines are changing who gets treated. Here's what it means in 2026.
Latest Guides
Recently updated health guides
Peptides Explained: What Each Peptide Does (Simple Guide)
A clear, practical guide to common peptides — what they do, how they work, and how they differ.
New 2025 High Blood Pressure Guideline: Prevention, Early Treatment, and Brain Health
The 2025 AHA/ACC guideline emphasizes prevention, early treatment, pregnancy care, and brain health in managing high blood pressure.
Alcohol and Health: Risks, Safe Limits, and Disease Prevention
How alcohol affects cancer risk, heart health, and long-term disease prevention.
MOTS-c: What It Is and What the Evidence Shows
An overview of MOTS-c, a mitochondrial-derived peptide studied in metabolism and aging research, including evidence limitations, regulatory status, and safety considerations.
Oxytocin: Established Uses and Evolving Research
A medical overview of oxytocin covering its established obstetric uses, research into social and mental health applications, evidence limitations, and safety considerations.
Tirzepatide: How It Works, Approved Uses, and What the Evidence Shows
A patient-facing reference guide to tirzepatide — a dual GIP/GLP-1 receptor agonist used for type 2 diabetes and weight management — covering its mechanism, approved uses, benefits, risks, and regulatory context.
CJC-1295: Uses, Mechanism, and What the Evidence Shows
An overview of CJC-1295, a synthetic growth hormone–releasing hormone analogue discussed in peptide clinics and research markets, including how it works, claimed uses, and current evidence.
Ipamorelin: Uses, Mechanism, and What the Evidence Shows
An overview of ipamorelin, a synthetic growth hormone secretagogue peptide, including how it works, claimed uses, and the current state of clinical evidence.